MDxHealth is trading 5.46% up now at $0.76 amid stronger market sentiment, after closing at $0.72 on August 27, 2026.
- No new company-specific announcement or late-breaking catalyst was identified.
- The latest major disclosure remains the August 13 second-quarter report, which showed $27.2 million in revenue and reaffirmed 2026 guidance.
- The S&P 500 gained 0.58% and Nasdaq Composite rose 1.52%, supported by upbeat Nvidia and Salesforce results.